ClinicalTrials.gov
ClinicalTrials.gov Menu

Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder (MATRIX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00224146
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : November 30, 2011
Sponsor:
Information provided by (Responsible Party):
Watson Pharmaceuticals